HS
VBIV

HighVista Strategies’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

HighVista Strategies’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,376
Closed -$129K – 129
2021
Q3 		$129K Buy
1,376
+423
+44% +$40.2K 0.09% 84
2021
Q2 		$95K Hold
953
– – 0.07% 96
2021
Q1 		$89K Hold
953
– – 0.07% 101
2020
Q4 		$79K Hold
953
– – 0.05% 104
2020
Q3 		$82K Buy
+953
New +$111K 0.06% 91

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HighVista Strategies's VBIV Position: Q4 2021 in Review

HighVista Strategies sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2021, closing a stake of 1,376 shares — an estimated $129K sold.

HighVista Strategies first reported a position in VBIV in Q3 2020 and held it in 5 quarters. The position peaked at $129K in Q3 2021. 134 funds tracked by Wall St. Rank hold VBIV as of Q4 2021.

  • HighVista Strategies reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 1,376 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2021, an estimated $129K.
  • HighVista Strategies first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 5 quarters.
  • HighVista Strategies's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $129K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.